Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_assertion type Assertion NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_head.
- NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_assertion description "[Versican (chondroitin sulphate proteoglycan-2) is overexpressed in BPH and prostate cancer and potentially contributes to disease pathology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_provenance.
- NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_assertion evidence source_evidence_literature NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_provenance.
- NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_assertion SIO_000772 15599946 NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_provenance.
- NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_assertion wasDerivedFrom befree-20140225 NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_provenance.
- NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_assertion wasGeneratedBy ECO_0000203 NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_provenance.